Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma

We previously reported that oesophageal squamous cell carcinoma (SCC) had a relatively high incidence of EGFR and HER-2 overexpression. Thus, anti-HER family targeting may become a promising approach to treat oesophageal SCC. In the present study, we investigated (a) the distribution of EGFR and HER...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaguchi, Y, Kono, K, Mimura, K, Mitsui, F, Sugai, H, Akaike, H, Fujii, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360355/
https://www.ncbi.nlm.nih.gov/pubmed/17622245
http://dx.doi.org/10.1038/sj.bjc.6603885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360355/
https://www.ncbi.nlm.nih.gov/pubmed/17622245
http://dx.doi.org/10.1038/sj.bjc.6603885

Ejemplares similares